Health Care
Manufacturers: Let’s Tackle Health Care Costs Without Sacrificing Innovation or Competitiveness
Fix the Real Problem: Unregulated PBMs
Washington, D.C. – National Association of Manufacturers President and CEO Jay Timmons released the following statement today in response to President Trump’s executive order instituting a “Most Favored Nation” policy for prescription drug pricing: “Biopharmaceutical manufacturers are investing in America. They are innovating cures and treatments for devastating diseases, and they are committed to ensuring …
Manufacturers Welcome Inclusion of PBM Reform in Government Funding Package, Urge Swift Passage to Tackle Health Care Costs
Permitting Reform Must Remain a Top Priority Next Year
Washington, D.C. – Following the release of Congress’ year-end government funding package, National Association of Manufacturers President and CEO Jay Timmons released the following statement on the inclusion of pharmacy benefit manager reforms: “Manufacturers commend House Speaker Mike Johnson, committee leadership and reform champions for their work on a government funding package that tackles rising …
NAM Backs Bipartisan Calls for PBM Reform During Lame Duck
Congress Must Act Immediately to Rein in PBMs
Washington, D.C. – Today, the National Association of Manufacturers voiced manufacturers’ support for efforts led by Rep. Buddy Carter (R-GA) to bring much-needed reform and transparency to pharmacy benefit managers. The NAM is a champion for PBM reform given that these underregulated middlemen drive up health care costs for manufacturers and manufacturing workers. Following a …
Manufacturers Launch Seven-Figure Ad Campaign Urging PBM Reforms in Lame Duck
Washington, D.C. – The National Association of Manufacturers has launched a seven-figure video and digital advertising campaign urging Congress to pass legislation this year to bring much-needed reform to pharmacy benefit managers, whose practices increase health care costs for manufacturers and manufacturing workers. The NAM’s
Improving Medical Supply Chain Resiliency
told members of Congress this month. What’s going on: “The COVID-19 pandemic brought to light the risks and instability resulting from concentration and choke points in medical supply chains, though the pandemic also showed how medical supply chains can quickly adjust to external shocks,” NAM Managing Vice President of Policy Chris Netram told Reps. Brad …
